Sitar Edward J 4
4 · INNOVATE BIOPHARMACEUTICALS, INC. · Filed May 4, 2020
Insider Transaction Report
Form 4
Sitar Edward J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-30+125,000→ 125,000 totalExercise: $0.70Exp: 2020-04-30→ Common stock (125,000 underlying) - Award
Stock Option (Right to Buy)
2020-04-24+176,156→ 176,156 totalExercise: $0.60From: 2020-04-24Exp: 2030-04-24→ Common stock (176,156 underlying)
Footnotes (2)
- [F1]The option vested in full on 4/24/2020.
- [F2]25% of the option will be deemed vested and exercisable on 4/30/2020, with the remainder vesting monthly over the next 48 months, subject to the executive's continued service with the Company through each applicable vesting date.